80.13USD+1.96%Mkt Cap: 255.05M $P/E: —1d ago
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States a…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap255.05M $
Enterprise Value204.94M $
Revenue (TTM)18.46M $
Gross Profit1.72M $
Net Income (TTM)-6.13M $
Revenue/Share6.598 USD
Last Price80.13 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees28
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.64
PEG—
EV/EBITDA-89.11
EV/Revenue11.10
P/S13.90
P/B4.99
EPS (TTM)-0.30
EPS (Forward)-7.74
52W Range
78.5913% of range90.50
52W High90.50 USD
52W Low78.59 USD
Profitability
Gross Margin9.30%
Oper. Margin-3569.44%
EBITDA Margin-12.46%
Profit Margin-31.60%
ROE-26.86%
ROA-20.48%
Growth
Revenue Growth-89.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF322.00K $
CapEx (TTM)47.00K $
FCF Margin—
FCF Yield—
Net Debt-51.97M $
Net Debt/EBITDA22.59
Balance Sheet
Debt/Equity0.04
Current Ratio8.84
Quick Ratio8.54
Book Value/Sh15.72 USD
Cash/Share16.16 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateMay 5, 2025
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)196.67 USD
Upside (mean)+145.4%
Target Range110.00 USD – 285.00 USD
$110.00+145.4% to mean$285.00
# Analysts3
Ownership
Shares Out.3.25M
Float529.12K
Insiders59.70%
Institutions41.53%
Short Interest
Short Ratio1.3d
Short % Float5.08%
Short % Out.1.64%
Shares Short53.55K
Short (prev mo.)47.50K
Technical
SMA 5078.39 (+2.2%)
SMA 20067.19 (+19.3%)
Beta1.16
S&P 52W Chg18.16%
Avg Vol (30d)71.10K
Avg Vol (10d)59.76K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—